L-Arginine Hydrochloride

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

2 Sponsors

5 Countries

Phase III

Phase III: 2

Oversight events:

3 temporary halts across 1 trial

View oversight register →

Indications tested

Gastroenteropancreatic neuroendocrine tumour disease 1

Sponsors using this IMP

Rayzebio Inc. 1 Universitaetsklinikum Heidelberg AöR 1

All trials

2 total

Phase 1b/3 global, randomized, controlled, open-label trial comparing treatment with RYZ101 to standard of care (SoC) therapy in subjects wi… Recruiting

2023-509334-19-00 Phase III 4 countries Rayzebio Inc.
Finerenone and renal oxidative stress Ended

2023-508266-15-00 Phase III 1 country Universitaetsklinikum Erlangen AöR

Showing 1–2 of 2 trials

← All drugs A–Z